Experience
Innovation
Longevity
Vision

A Tapestry of Professionals

Delivering High-Quality Outcomes

for Complex Issues

Meet Our Attorneys
Experience and innovation.
Longevity and vision.
Michael V. Benedetto
PresidentShareholder •
Michael V. Benedetto
Meet Our Attorneys
Experience and innovation.
Longevity and vision.
Mitchell J. Ansell
Shareholder
Mitchell J. Ansell
Meet Our Attorneys
Experience and innovation.
Longevity and vision.
Brian E. Ansell
Shareholder
Brian E. Ansell
Meet Our Attorneys
Experience and innovation.
Longevity and vision.
Allison Ansell
Shareholder
Allison Ansell
Meet Our Attorneys
Experience and innovation.
Longevity and vision.
James G. Aaron
Shareholder
James G. Aaron
Current Focus

Bankruptcy Law

Recent

News

BANKRUPTCY DEPARTMENT UPDATE – FEBRUARY 2023

Led by Department Chair James G. Aaron, in coordination with partners Joshua S. Bauchner and Anthony J. D’Artiglio, Ansell’s attorneys are well versed in the intricacies of bankruptcy practice. Our bankruptcy attorneys are here to offer the knowledge and advice about the benefits and detriments of the different types of

Read Article
Recent

News

Ansell Grimm & Aaron Congratulates Clients for Securing Cannabis Licenses

March 8, 2023

Ansell Grimm & Aaron, PC is pleased to congratulate its latest clients to secure annual cannabis licenses from the Cannabis Regulatory Commission. The Social Leaf, LLC was awarded an Annual Class Five Retailer License, and CSDE Manufacturing, LLC was awarded an Annual Class One Cultivator License. The Commission issues licenses for medicinal and recreational cannabis […]

Read More »

9th Circuit to Decide Whether the Federal Government Can Continue to Deprive End-of-Life Patients of Psilocybin's Palliative Benefits

March 5, 2023

By Joshua S. Bauchner and Rahool Patel Much ink has been spilled over the past decade about the absurdity of the federal government’s insistence on maintaining marijuana’s listing as a Schedule I drug with “no accepted medical use” under the Controlled Substances Act (CSA) despite ample evidence of and consensus about marijuana’s therapeutic and medical […]

Read More »

CONTROLLED SUBSTANCES AND REGULATORY LAW DEPARTMENT UPDATE - FEBRUARY 2023

February 16, 2023

          Ansell Files Amicus Curiae Brief In Support Of De-Scheduling Psilocybin Ansell Grimm & Aaron, PC once again proudly joins the National Organization for the Reform of Marijuana Laws (“NORML”) in securing access for patients, especially veterans, to the scientifically established medicinal benefits of psilocybin. Americans waited a half-century before gaining […]

Read More »

No aspect of advertisements on the site has been approved by the Supreme Court of New Jersey or the American Bar Association.